Literature DB >> 576178

Transitory growth hormone deficiency successfully treated with human growth hormone.

O Trygstad.   

Abstract

This study was carried out in order to determine whether children with a transitory type of growth hormone deficiency showed an accelerated growth in height velocity on treatment with human growth hormone (HGH). Following careful diagnostic routine procedures 13 extremely short children were diagnosed as having isolated growth hormone deficiency, and were successfully treated with HGH. A true isolated growth hormone deficiency was present in 5 of the children, whereas 8 showed a normal increase in serum growth hormone on repeated growth hormone stimulation tests after their development of puberty and termination of HGH treatment. Three boys with bone ages of 5.5, 8.0 and 9.5 years showed an undisputable effect following HGH administration. They showed an initial growth at the start of treatment, and a second growth spurt during development of puberty. Two of the boys reached final statures of 14 cm taller than the predicted heights. The other patients, including the children with true isolated growth hormone deficiency showed an initial spurt of growth at the start of the HGH treatment immediately followed by a pubertal growth spurt. The mean accleration of height velocity for the children with true isolated growth hormone deficiency was from 3.4 cm during the year before treatment to 7.0 cm during the first year on treatment, as compared to 2.8 and 7.4 cm, respectively, for the children with transitory growth hormone deficiency. A girl with severe anorexia nervosa who had a transitory growth hormone deficiency, showed an accelerated high velocity from 1.1 cm to 7.6 cm during the first year following treatment with HGH.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 576178     DOI: 10.1530/acta.0.0840011

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  7 in total

1.  Is the persistence of isolated GH deficiency in adulthood predicted by anatomical hypothalamic-pituitary alterations?

Authors:  S Vannelli; B Stasiowska; J Bellone; G Aimaretti; S Bellone; T Avataneo; S Cirillo; L Benso
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

2.  Normal variant short stature.

Authors:  P S Menon; R K Menon; A Gupta
Journal:  Indian J Pediatr       Date:  1983 Sep-Oct       Impact factor: 1.967

3.  A new task for human growth hormone?

Authors:  M A Preece
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-31

Review 4.  Stunted growth with more or less normal appearance.

Authors:  J R Bierich; H Enders; U Heinrich; R Huenges; M B Ranke; D Schoenberg
Journal:  Eur J Pediatr       Date:  1982-12       Impact factor: 3.183

5.  The efficacy of growth hormone in different types of growth failure. An analysis of 101 cases.

Authors:  H L Lenko; S Leisti; J Perheentupa
Journal:  Eur J Pediatr       Date:  1982-05       Impact factor: 3.183

6.  Testing with growth hormone-releasing factor (GRF(1-29)NH2) and somatomedin C measurements for the evaluation of growth hormone deficiency.

Authors:  M B Ranke; M Gruhler; R Rosskamp; G Brügmann; A Attanasio; W F Blum; J R Bierich
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

7.  Growth hormone state after completion of treatment with growth hormone.

Authors:  P E Clayton; D A Price; S M Shalet
Journal:  Arch Dis Child       Date:  1987-03       Impact factor: 3.791

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.